干细胞临床研究现状,Totipotent stem cell,Pluripotent stem cell,Multipotent stem cell,Terminally Differentiated Cell,2009年3月奥巴马取消美国对胚胎干细胞研究限制后，推动了干细胞的临床研究。,.,October 11, 2010 - Geron Corporation (Nasdaq: GERN) today announced the enrollment of the first patient in the companys clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1. The FDA notification enables Geron to move forward with the worlds first clinical trial of a human embryonic stem cell (hE
